South & Central America Electronic Patient-Reported Outcomes Market Forecast to 2031 - Regional Analysis - by Delivery Mode, Application, and End User

The South & Central America electronic patient-reported outcomes (ePROS) market was valued at US$ 32.06 million in 2023 and is expected to reach US$ 86.04 million by 2031; it is estimated to register a CAGR of 13.1% from 2023 to 2031.

Rising Adoption of Telehealth and Remote Monitoring Fuels South & Central America Electronic Patient-Reported Outcomes (ePROS) Market

The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions.

For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.

South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Overview

Brazil is a significant destination for clinical trials. According to Clinical Trials Arena, Brazil accounted for 1.7% share of the overall clinical trials activities worldwide in 2021. Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin) in July 2022, describing it as the first step toward adopting its decentralized clinical trial delivery model in Latin America. IBPClin claims to have conducted over 160 industry-sponsored research studies, registering more than 7,000 participants across 12 Brazilian states. In addition, digital initiatives for the transformation of healthcare in the country are rapidly increasing.

For instance, The SUS Digital is driving the digital transformation of the healthcare system in Brazil. The initiative expands citizens' access to healthcare services by incorporating technologies, thereby promoting a more integrated and efficient approach to healthcare. The program also covers data monitoring and evaluation, information systems, platforms, and application development. Therefore, the increasing number of clinical trials and surging digital transformation of the healthcare system in the country are likely to contribute the market growth in the coming years.

South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Revenue and Forecast to 2031 (US$ Million)

South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Segmentation

The South & Central America electronic patient-reported outcomes (ePROS) market is categorized into delivery mode, application, end user, and country.

By delivery mode, the South & Central America electronic patient-reported outcomes (ePROS) market is bifurcated into cloud based and on-premises. The cloud based segment held a larger share of the South & Central America electronic patient-reported outcomes (ePROS) market share in 2023.

• In terms of application, the South & Central America electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the South & Central America electronic patient-reported outcomes (ePROS) market share in 2023.
• By end user, the South & Central America electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held the largest share of the South & Central America electronic patient-reported outcomes (ePROS) market share in 2023.
• Based on country, the South & Central America electronic patient-reported outcomes (ePROS) market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil segment held the largest share of South & Central America electronic patient-reported outcomes (ePROS) market in 2023.

Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC are some of the leading companies operating in the South & Central America electronic patient-reported outcomes (ePROS) market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America electronic patient-reported outcomes (ePROS) market.
• Highlights key business priorities to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America electronic patient-reported outcomes (ePROS) market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America electronic patient-reported outcomes (ePROS) market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.